Enfusion Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $8.63
- Today's High:
- $8.85
- Open Price:
- $8.7
- 52W Low:
- $7.37
- 52W High:
- $16.76
- Prev. Close:
- $8.82
- Volume:
- 278333
Company Statistics
- Market Cap.:
- $605.20 million
- Book Value:
- 0.86
- Revenue TTM:
- $157.18 million
- Operating Margin TTM:
- 3.24%
- Gross Profit TTM:
- $103.25 million
- Profit Margin:
- 1.63%
- Return on Assets TTM:
- 2.81%
- Return on Equity TTM:
- 4.04%
Company Profile
Enfusion Inc had its IPO on 2021-10-21 under the ticker symbol ENFN.
The company operates in the Technology sector and Software-Application industry. Enfusion Inc has a staff strength of 1,006 employees.
Stock update
Shares of Enfusion Inc opened at $8.7 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $8.63 - $8.85, and closed at $8.66.
This is a -1.81% slip from the previous day's closing price.
A total volume of 278,333 shares were traded at the close of the day’s session.
In the last one week, shares of Enfusion Inc have increased by +0.7%.
Enfusion Inc's Key Ratios
Enfusion Inc has a market cap of $605.20 million, indicating a price to book ratio of 10.7775 and a price to sales ratio of 4.533.
In the last 12-months Enfusion Inc’s revenue was $157.18 million with a gross profit of $103.25 million and an EBITDA of $9.47 million. The EBITDA ratio measures Enfusion Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Enfusion Inc’s operating margin was 3.24% while its return on assets stood at 2.81% with a return of equity of 4.04%.
In Q1, Enfusion Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 20%.
Enfusion Inc’s PE and PEG Ratio
- Forward PE
- 67.1141
- Trailing PE
- 201.5
- PEG
Its diluted EPS in the last 12-months stands at $0.04 per share while it has a forward price to earnings multiple of 67.1141 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Enfusion Inc’s profitability.
Enfusion Inc stock is trading at a EV to sales ratio of 4.8034 and a EV to EBITDA ratio of -2.2601. Its price to sales ratio in the trailing 12-months stood at 4.533.
Enfusion Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $121.49 million
- Total Liabilities
- $13.71 million
- Operating Cash Flow
- $-2550000.00
- Capital Expenditure
- $2.55 million
- Dividend Payout Ratio
- 0%
Enfusion Inc ended 2024 with $121.49 million in total assets and $0 in total liabilities. Its intangible assets were valued at $121.49 million while shareholder equity stood at $63.71 million.
Enfusion Inc ended 2024 with $0 in deferred long-term liabilities, $13.71 million in other current liabilities, 115000.00 in common stock, $-176012000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $54.60 million and cash and short-term investments were $54.60 million. The company’s total short-term debt was $5,013,000 while long-term debt stood at $0.
Enfusion Inc’s total current assets stands at $86.65 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $24.36 million compared to accounts payable of $1.29 million and inventory worth $0.
In 2024, Enfusion Inc's operating cash flow was $-2550000.00 while its capital expenditure stood at $2.55 million.
Comparatively, Enfusion Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $8.66
- 52-Week High
- $16.76
- 52-Week Low
- $7.37
- Analyst Target Price
- $11.25
Enfusion Inc stock is currently trading at $8.66 per share. It touched a 52-week high of $16.76 and a 52-week low of $16.76. Analysts tracking the stock have a 12-month average target price of $11.25.
Its 50-day moving average was $9.66 and 200-day moving average was $9.84 The short ratio stood at 3.66 indicating a short percent outstanding of 0%.
Around 735.5% of the company’s stock are held by insiders while 10462.7% are held by institutions.
Frequently Asked Questions About Enfusion Inc
Similar Industry Stocks (Software-Application)
Most Active
Top Gainers
Top Losers
About
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. The company was founded in 1997 and is headquartered in Chicago, Illinois.